The Tecan Group (SIX Swiss Exchange: TECN), a leading global provider of laboratory instruments and solutions, and Enigma Diagnostics Limited, the decentralised and point-of-care molecular diagnostics ...
Automated Liquid Handling and Workflow Solutions for the Life Sciences Tecan is a leading global provider of laboratory instruments and solutions for life science research, biopharmaceuticals, ...
Tecan unveiled its new Cavro ® Magni Flex OEM robotic liquid handling instrument development platform at this year’s AACC Annual Scientific Meeting & Clinical Lab Expo. This modular and scalable ...
Substantial reductions in OEM customer forecasts as the main factor negatively impacting outlook for 2024 since last update in August Life Sciences Business continues to face a challenging market ...
The additions enhance Cell Q’s capabilities to scale high-throughput sample prep, liquid-handling verification, COI/COC preservation, full-spectrum flow cytometry, and synthetic controls in Cell Q.
Medical device engineers face escalating integration challenges as instruments grow more complex and component‑dense. Tecan addresses this complexity at its Tecan contract design and manufacturing ...
Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan reports 2024 financial results, enhancing operational resilience amid challenging conditions Financial ...
The Tecan Group and Enigma Diagnostics Limited announced the signing of a manufacturing and supply agreement for Enigma’s ML instruments. Under the agreement, Tecan will industrialize and deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results